GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Basilea Pharmaceutica AG Allschwil BSLN.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

72.20

+1.69%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CHF, from our data supplier.

FY2025

Revenue

CHF 232.4m

FY2016FY2025

Net income

CHF 40.2m

FY2016FY2025

Free cash flow

CHF 59.2m

FY2016FY2025

Shareholders' equity

CHF 127.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCHF 232.4mCHF 208.5mCHF 157.6mCHF 147.8mCHF 148.1mCHF 127.6mCHF 134.4mCHF 132.6mCHF 101.5mCHF 66.0m
Research and developmentCHF 105.9mCHF 77.1mCHF 77.9mCHF 73.8mCHF 93.2mCHF 97.4mCHF 102.7mCHF 105.1mCHF 55.4mCHF 49.0m
Operating incomeCHF 51.6mCHF 61.2mCHF 19.2mCHF 18.5mCHF 1.2m−CHF 23.3m−CHF 16.0m−CHF 24.6m−CHF 14.1m−CHF 44.0m
Net incomeCHF 40.2mCHF 77.6mCHF 10.5mCHF 12.1m−CHF 6.8m−CHF 14.7m−CHF 22.4m−CHF 31.4m−CHF 19.4m−CHF 51.3m
Diluted earnings per share3.295.590.871.02-0.58-1.35-2.08-2.90-1.78-5.07

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCHF 282.0mCHF 257.8mCHF 173.3mCHF 220.8mCHF 247.3mCHF 229.8mCHF 221.5mCHF 281.8mCHF 351.2mCHF 327.8m
Cash and short-term investmentsCHF 162.3mCHF 120.7mCHF 59.9mCHF 84.7mCHF 148.7mCHF 167.3mCHF 131.0mCHF 223.0mCHF 260.7mCHF 239.0m
Total liabilitiesCHF 154.1mCHF 176.8mCHF 183.3mCHF 241.6mCHF 305.9mCHF 331.8mCHF 314.4mCHF 348.4mCHF 392.6mCHF 362.8m
DebtCHF 79.6mCHF 95.9mCHF 110.9mCHF 168.8mCHF 218.0mCHF 239.7mCHF 197.7mCHF 197.0mCHF 196.2mCHF 195.5m
Shareholders' equityCHF 127.9mCHF 81.0m−CHF 10.0m−CHF 20.7m−CHF 58.6m−CHF 102.0m−CHF 93.0m−CHF 66.7m−CHF 41.4m−CHF 35.0m
Shares outstanding12m14m12m12m12m11m11m11m11m10m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCHF 62.1mCHF 74.4mCHF 14.2mCHF 7.1m−CHF 32.0m−CHF 54.1m−CHF 63.8m−CHF 79.2mCHF 19.0m−CHF 75.0m
Capital spending−CHF 2.9m−CHF 1.7m−CHF 1.0m−CHF 3.3m−CHF 860,000−CHF 2.3m−CHF 404,000−CHF 419,000−CHF 711,000−CHF 394,000
Free cash flowCHF 59.2mCHF 72.7mCHF 13.2mCHF 3.8m−CHF 32.9m−CHF 56.4m−CHF 64.2m−CHF 79.6mCHF 18.3m−CHF 75.4m
Dividends paid——−CHF 57.3m—−CHF 23.2m—————

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Mar 2023
RevenueCHF 119.0mCHF 128.4mCHF 52.0mCHF 132.3mCHF 76.3mCHF 72.7mCHF 84.9mCHF 42.5m
Operating incomeCHF 31.6mCHF 27.6mCHF 12.0mCHF 51.9mCHF 9.3m−CHF 17.7mCHF 36.9mCHF 16.2m
Net incomeCHF 27.9mCHF 24.4mCHF 7.9mCHF 56.9mCHF 20.7m−CHF 21.4mCHF 31.8mCHF 15.9m
Diluted earnings per share2.022.000.654.091.49-1.782.651.15
Cash from operationsCHF 18.0mCHF 39.0mCHF 23.0mCHF 56.0mCHF 17.0m−CHF 7.0mCHF 21.0m—
Capital spending—−CHF 2.0m—−CHF 1.0m————
Free cash flow—CHF 37.0m—CHF 55.0m————
Total assetsCHF 298.0mCHF 282.0mCHF 248.8mCHF 257.8mCHF 188.7mCHF 173.3mCHF 230.0m—
Cash and short-term investmentsCHF 176.0mCHF 162.3mCHF 128.4mCHF 120.7mCHF 69.5mCHF 59.9mCHF 90.9m—
DebtCHF 2.1mCHF 79.6mCHF 86.1mCHF 100.0mCHF 99.8mCHF 113.0mCHF 153.2m—
Shareholders' equityCHF 162.4mCHF 127.9mCHF 103.2mCHF 81.0mCHF 16.8m−CHF 10.0mCHF 15.0m—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.3%12.7%16.0%
Operating income40.7%——
Net income49.0%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin25.6%20.2%12.6%-2.1%
Net margin26.7%18.8%11.6%-4.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings16.67.440.545.1-70.9-39.2-22.5-13.8-42.6-14.4
Price to sales2.92.82.73.73.34.53.83.38.111.2

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 11 Apr 2013.

FY2013
Paid in the year5.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.